Oncolytic herpes simplex virus delivery of dual CAR targets of CD19 and BCMA as well as immunomodulators to enhance therapeutic efficacy in solid tumors combined with CAR T cell therapy

利用溶瘤性单纯疱疹病毒递送靶向CD19和BCMA的双CAR以及免疫调节剂，以增强CAR-T细胞疗法在实体瘤中的治疗效果。